epocrates

Trending Patient News: Week of March 16, 2026

March 20, 2026

Keeping you a step ahead is our priority. That's why we've gathered some of the top stories your patients might be seeing. Here are this week's highlights:

Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

(NBC News)—A recall of millions of Abbott FreeStyle Libre sensors follows reports that faulty readings may have contributed to serious injuries and deaths, raising safety concerns among patients who depend on continuous glucose monitoring. Read more

Woman suffered panic attacks for 20 years—a test changed everything

(Newsweek)—Doctors discovered that decades of unexplained panic symptoms were actually focal seizures caused by temporal lobe epilepsy, highlighting how neurological conditions can be misdiagnosed as psychiatric disorders. Read more

What to know about cychlorphine, the synthetic opioid 10 times stronger than fentanyl

(The Hill)—Warnings from public health officials point to a newly circulating illicit opioid associated with clusters of overdose deaths that is difficult to detect with standard test strips and often unknowingly mixed into other street drugs. Read more

Influencers push ‘parasite cleanses’ but doctors say to steer clear

(NPR)—Doctors are warning that social‑media–driven claims about widespread parasites and “cleanses” are prompting patient anxiety and risky self‑treatment, despite little evidence that such products are effective or safe. Read more

Mothers ‘terrified’ as children could lose treatments after FDA denials

(Newsweek)—Parents of children with rare, life‑threatening diseases say FDA denials of experimental drugs could cut off access to therapies currently provided through trials or expanded‑access programs, leaving families uncertain about their children’s care and survival. Read more

As parents clamor for a treatment touted for autism, doctors hesitate to prescribe it

(NPR)—After federal officials publicized leucovorin as a potential autism treatment, clinicians are grappling with parental demand despite limited evidence and revised FDA guidance narrowing its use to a rare genetic condition. Read more

Protein invades the comfort-food aisle

(Axios)—Major food brands are rolling out protein‑fortified versions of familiar comfort foods—such as mac and cheese, chips, and ice cream—to capitalize on surging demand fueled by GLP‑1 drugs and shifting consumer nutrition priorities. Read more

Content availability may vary; some sources may require payment or registration.

Any views, thoughts, and opinions expressed in these articles are solely that of the publication and/or author and do not reflect the views, opinions, policies, or position of epocrates and athenahealth.